文献速递脑血管病外科神经重症

橙皮苷对实验性大鼠蛛网膜下腔出血后脑血管痉挛的神经保护作用:生化、病理与组织形态学分析

Neuroprotective Effects of Hesperidin on Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Rats: Biochemical, Pathologic, and Histomorphometric Analysis.
PubMed 文献 · World Neurosurg · 2018-11-15

研究将40只白化Wistar大鼠随机分为5组(每组n=8),通过枕大池注射自体血建立蛛网膜下腔出血模型,分别给予生理盐水(100 mg/kg)或低剂量(50 mg/kg)、高剂量(100 mg/kg)橙皮苷腹腔注射,每日两次共48小时。结果发现橙皮苷对丙二醛水平无显著降低作用,但高、低剂量橙皮苷组血管壁厚度较蛛网膜下腔出血组变薄,管腔直径显著增大。作者认为橙皮苷可能对蛛网膜下腔出血治疗有用。

要点

  • 橙皮苷未显著降低丙二醛水平,对脂质过氧化无影响。
  • 橙皮苷组血管壁较蛛网膜下腔出血组薄,管腔直径显著增大。
  • 作者认为橙皮苷可能对蛛网膜下腔出血治疗有用。

核心结论

  • 橙皮苷对丙二醛相关的脂质过氧化活性无影响,但可能因其对血管壁厚度和管腔直径的有益作用而在蛛网膜下腔出血治疗中有用。

研究设计与样本

  • 研究将40只白化Wistar大鼠随机分为5组,每组n=8:G1无实验干预;G2蛛网膜下腔出血;G3蛛网膜下腔出血+生理盐水(100 mg/kg);G4蛛网膜下腔出血+低剂量橙皮苷(50 mg/kg);G5蛛网膜下腔出血+高剂量橙皮苷(100 mg/kg)。
  • 蛛网膜下腔出血模型通过从大鼠尾动脉取自体血0.15 cc,经颅颈交界处注入枕大池建立。
  • 药物以腹腔注射方式给药,每日两次,持续48小时,期末处死大鼠。

主要发现

  • 药物组(G4和G5)中丙二醛水平未见统计学显著降低。
  • 蛛网膜下腔出血组(G2、G3)基底动脉薄切片显示严重管腔狭窄和血管壁增厚。
  • 橙皮苷给药组(G4、G5)血管壁厚度测量值较蛛网膜下腔出血组(G2、G3)更薄,管腔直径显著大于蛛网膜下腔出血组(G2、G3)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined the protective effects of hesperidin on cerebral vasospasm by establishing an experimental rat model of subarachnoid hemorrhage and performing biochemical, pathologic, and histomorphometric analysis on these data. METHODS: Forty albino Wistar rats were randomly divided into 5 groups of n = 8 in each: group (G)1, no experimental interventions; G2, subjected to subarachnoid hemorrhage; G3, subjected to subarachnoid hemorrhage and administered saline (100 mg/kg); G4, subjected to subarachnoid hemorrhage and treated with low-dose hesperidin (50 mg/kg); and G5, subjected to subarachnoid hemorrhage and treated with high-dose hesperidin (100 mg/kg). Subarachnoid hemorrhage was created by injecting 0.15 cc of autologous blood taken from the rat-tail artery and injected into the cisterna magna from the craniocervical junction. Drugs were administered intraperitoneally as twice daily doses for 48 hours. Rats were euthanized at the end of this period. RESULTS: No statistically significant decrease was observed in malondialdehyde levels, which is the end-product of lipid peroxidation, among the drug groups (G4 and G5). Thin sections prepared from the basilar artery were examined morphologically. Severe luminal narrowing and vessel-wall thickening were observed in the subarachnoid hemorrhage groups (G2, G3). In the hesperidin-administered groups (G4, G5), it was determined that vessel wall thickness measurements revealed thinner walls than in the subarachnoid hemorrhage groups (G2, G3) and the luminal diameters were significantly larger than in the subarachnoid hemorrhage groups (G2, G3). CONCLUSIONS: These findings suggest that hesperidin has no effect on malondialdehyde-associated lipid-peroxidation activity; however, it might be useful in subarachnoid hemorrhage therapy because of its beneficial effects on vessel wall thickness and luminal diameters.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Aydogmus E, Gul S, Bahadir B, et al. Neuroprotective Effects of Hesperidin on Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Rats: Biochemical, Pathologic, and Histomorphometric Analysis. World Neurosurg. 2018. PMID: 30448580. doi:10.1016/j.wneu.2018.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。